Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Microplastics in the Human Respiratory System
This update covers a clinical trial investigating microplastics in the human respiratory system. The study relates to non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer
A clinical trial update evaluating the value of the 68Ga-grazytracer PET imaging tracer in guiding immunotherapy for stage III non-small-cel…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Cancer Patient Remote Monitoring for Timely Communication Study
This clinical trial update describes a remote monitoring study intended to improve timely communication for cancer patients with stage IV no…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) [NA]
Clinical trial update describing a study focusing on patient-reported outcomes in advanced pancreatic cancer or non-small cell lung cancer t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer [Phase 1]
Phase 1 study evaluating pulse radiotherapy to overcome metastatic immune system evasion in non-small cell lung cancer; the trial status is …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Application of Machine Learning Algorithms to Identify Optimal Candidates for Primary Tumor Resection in Patients with Metastatic Non-small Cell Neuroendocrine Tumors
This study update reports completion of a trial applying machine learning to identify metastatic non-small cell lung cancer patients who may…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC [Phase 3]
A Phase 3 bridging study comparing PF-06439535 plus paclitaxel-carboplatin versus bevacizumab plus paclitaxel-carboplatin in advanced non-sm…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours [Phase 1, Phase 2]
A first-in-human Phase 1/2 study evaluating the safety and tolerability of AZD8853 in selected advanced/metastatic solid tumors (urinary bla…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Clinical trial update on detecting tumor cells and tumor DNA in blood, urine, and bone marrow of patients with solid cancers; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of combining Bojungikki-tang with pembrolizumab in patients with advanced non-small cell …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Local Injection and Systemic Therapy in the Treatment of NSCLC. [Phase 2]
A Phase 2 clinical trial is described for treating Non-small cell lung cancer using local injection plus systemic therapy, with the study st…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial [Phase 2]
A Phase II multicenter trial is evaluating the efficacy of a PD-1 inhibitor in combination therapy for non-small cell lung cancer patients w…
-
FDA approval · 2024-09-30FDA Approved: LUMAKRAS — Supplemental Application (Amgen Inc)
FDA approved Amgen's supplemental application for LUMAKRAS (sotorasib), updating the labeling to reflect the information approved in the sub…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences [NA]
An ongoing clinical trial evaluates whether advance care planning improves the consistency of life-sustaining-treatment preferences between …
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Descriptive Observational Study ALK-2016-CPHG
A descriptive observational study of crizotinib in non-small cell lung cancer with ALK or ROS1 rearrangements has completed, and results wer…
-
CLINICAL_TRIALS withdrawal · 2024-09-27Clinical Trial Update: An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer [Phase 1]
An investigational PET/CT imaging tracer, 124I-hJAA-F11, being evaluated for diagnosing lung cancer in a Phase 1 trial has been withdrawn.
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant tislelizumab plus chemotherapy for initially unresectable stage IIIA/N2 non-small cell lung cancer is…
-
FDA approval · 2024-09-25FDA Approved: TAGRISSO — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Tagrisso (osimertinib) from AstraZeneca Pharmaceuticals LP. This action updates the labeling…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Icotinib for Completed Resected IB NSCLC With EGFR Mutation [Phase 2]
This update reports the completion of a Phase 2 trial of icotinib for resected Stage IB non-small cell lung cancer with EGFR mutation, with …
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy [Phase 2]
Phase 2 trial results update for durvalumab after radiation therapy in patients with stage 3 unresectable non-small cell lung cancer who are…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China [Phase 1, Phase 2]
First-in-human study of JAB-3068, an SHP2 inhibitor, in adults with advanced solid tumors in China, including non-small cell lung cancer, he…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy [Phase 3]
Phase 3 trial evaluating intratumoral toluenesulfonamide (PTS) for stage IV driver gene-negative non-small cell lung cancer, with or without…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: AB122 Platform Study [Phase 1]
Phase 1 AB122 platform study is currently recruiting for advanced or metastatic solid tumors, including pancreatic ductal adenocarcinoma and…